Revenue Growth and SHOP Performance
Diversified Healthcare Trust reported total revenues of $379.6 million for the fourth quarter, marking a 5% year-over-year increase. SHOP occupancy reached 80% for the first time since Q1 2020, with a 56% improvement in SHOP NOI and a 7.3% increase in SHOP revenues.
Successful Property Sales and Strategic Dispositions
Completed property sales close to $179 million in Q1 2025, including the sale of the Muse Life Science campus for $159 million. Additionally, there are active marketing efforts for 34 communities with signed term sheets for five communities targeting proceeds of $68 million by Q2 2025.
Financing Strategy and Debt Management
Signed term sheets for $340 million in anticipated loan proceeds with a favorable weighted average interest rate of approximately 6.5%. Progress made in addressing the 2025 and 2026 debt maturities with significant asset sales and refinancing plans.
Increased FFO and NOI
Normalized FFO for the fourth quarter was $5.3 million or $0.02 per share, representing a 31% sequential quarter increase. Same property cash basis NOI saw an 18.7% improvement year over year.